INIS
anticoagulants
8%
applications
6%
automation
7%
bones
12%
breasts
14%
cancer
13%
capacity
6%
carbohydrates
9%
comparative evaluations
19%
concentration
6%
coronaviruses
12%
data
13%
defects
6%
detection
6%
diseases
12%
doses
6%
endometrium
6%
estradiol
8%
estrogens
59%
evaluation
28%
global analysis
6%
globulins
12%
guidelines
5%
hemostatics
19%
hormones
23%
in vitro
6%
inhibition
6%
interlaboratory comparisons
12%
laboratories
26%
lipids
12%
liver
5%
membranes
7%
men
12%
menopause
12%
metabolism
12%
mutations
18%
patients
24%
peaks
5%
performance
16%
populations
6%
progestin
6%
proteins
73%
range
14%
receptors
24%
reviews
33%
risks
37%
safety
7%
screening
11%
sensitivity
28%
sex
6%
standardization
20%
steroids
9%
symptoms
15%
tamoxifen
12%
testing
16%
therapy
12%
thrombin
100%
thrombosis
12%
values
5%
wave forms
6%
women
59%
Pharmacology, Toxicology and Pharmaceutical Science
Activated Protein C
22%
Activated Protein C Resistance
41%
APC
16%
Bleeding
13%
Blood Stasis
18%
Breast Cancer
5%
Drospirenone
12%
Estetrol
24%
Estrogen Receptor
11%
Estrogen Receptor Positive Breast Cancer
12%
Ethinylestradiol
7%
Hemostatic Agent
19%
Levonorgestrel
10%
Menopausal Syndrome
12%
Observational Study
12%
Oral Contraceptive
13%
Oral Contraceptive Agent
34%
Placebo
6%
Progestin
6%
Tamoxifen
12%
Thrombin
61%
Thrombogenicity
5%
Thrombosis
8%
Venous Thromboembolism
13%
Keyphrases
Activated Protein C
12%
Activated Protein C Resistance
7%
APC Resistance
12%
Bone Turnover
12%
Breast Cancer
12%
Breast Cancer Patients
12%
Childbearing Women
12%
Climacteric Symptoms
12%
Drospirenone
12%
Endogenous Thrombin Potential
7%
Estrogen Receptor
9%
Estrogen Receptor-positive Breast Cancer
12%
Factor V Leiden mutation
8%
Global Coagulation Tests
12%
Hemostasis Parameters
12%
High Users
6%
Hypercoagulability
12%
Levonorgestrel
6%
Literature Review Analysis
12%
Membrane Estrogen Receptor
8%
Menopause Symptoms
12%
Nuclear Estrogen Receptor
8%
Oral Contraception
12%
Oral Contraceptives
12%
Panel Review
12%
Projet
6%
Randomized Double-blind Study
12%
Sensitivity Ratio
16%
Thrombin Generation Assay
7%
User Satisfaction
6%